What are Strata Critical Medical, Inc. Class A Common Stock's total assets?

Strata Critical Medical, Inc. Class A Common Stock (SRTA) holds $327.6M in total assets, up 30.8% year over year.

How much debt does Strata Critical Medical, Inc. Class A Common Stock have?

Strata Critical Medical, Inc. Class A Common Stock carries $4.5M in total debt against $285.7M of shareholders' equity, a debt-to-equity ratio of 0.02.

How much cash does Strata Critical Medical, Inc. Class A Common Stock have?

Strata Critical Medical, Inc. Class A Common Stock holds $59.0M in cash and equivalents.

Can Strata Critical Medical, Inc. Class A Common Stock cover its short-term obligations?

Its current ratio is 5.93 — current assets exceed current liabilities.

Where does Strata Critical Medical, Inc. Class A Common Stock's balance sheet data come from?

Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Strata Critical Medical, Inc. Class A Common Stock SRTA Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$58.99M+65.3%	$31.23M+59.0%	$23.02M+7.5%	$60.32M+113%	$35.69M-6.2%
Short-term investments	$66K-99.9%	$30.26M-72.2%	$53.17M-54.3%	$54.67M-52.7%	$85.18M-25.4%
Restricted cash	$264K-69.2%	$264K+0.4%	$263K-80.9%	$1.56M-24.0%	$858K-34.1%
Accounts receivable, net	$39.6M+79.0%	$39.96M+102%	$37.54M+53.3%	$28.17M+1.6%	$22.13M-6.0%
Prepaid expenses and other current assets	$25.49M+173%	$24.74M+429%	$8.76M-8.4%	$13.32M+19.2%	$9.32M-48.7%
Total current assets	$124.15M-18.5%	$126.19M-21.5%	$122.48M-28.7%	$156.48M-14.5%	$152.31M-21.5%
Property and equipment, net	$40.09M+23.1%	$36.44M+28.0%	$38.56M+26.2%	$33.7M+52.5%	$32.57M+839%
Accumulated depreciation	$7.86M+24.5%	$6.29M+144%	$4.94M+12.4%	$7.09M+97.3%	$6.31M—
Operating lease right-of-use assets	$4.2M-51.5%	$3.11M+9.7%	$3.27M+4,092,499,900%	$8.45M+9,497,752,709%	$8.65M+9,719,101,024%
Goodwill	$88.59M+111%	$88.21M+468%	$84.61M+97.0%	$44.25M+11.8%	$42.04M+5.7%
Intangible assets, net	$46.31M+242%	$47.5M+496%	$49.75M+256%	$13.58M-0.9%	$13.53M-30.7%
Deferred tax assets	$271K+54.9%	$348K—	$181K-40.1%	$210K-47.8%	$175K-51.0%
Other non-current assets	$89K-93.9%	$167K+41.5%	$8.58M+839%	$1.46M+57.1%	$1.45M+1.0%
Held-to-maturity securities	$66K-99.9%	$30.26M-72.2%	$53.17M-54.3%	$54.67M-52.7%	$85.18M-25.4%
Total assets	$327.62M+30.8%	$325.47M+26.8%	$335.08M+18.4%	$257.92M-8.0%	$250.55M-11.4%
Accounts payable	$19.96M+90.0%	$19.14M+108%	$27.22M+69.8%	$13.68M-18.9%	$10.51M-3.1%
Operating lease liabilities, current	$987K-70.6%	$652K-4.4%	$654K-85.4%	$3.52M-15.1%	$3.36M-24.1%
Total current liabilities	$20.94M-4.3%	$19.79M-12.9%	$27.87M+2.5%	$26.31M-13.1%	$21.88M-5.9%
Operating lease liabilities, non-current	$3.48M-39.0%	$2.66M+13.7%	$2.82M-85.4%	$5.32M-70.2%	$5.71M-73.0%
Other non-current liabilities	$17.12M—	$22.07M—	$18.26M—	——	——
Total liabilities	$22.06M-28.4%	$25.74M-25.9%	$52.08M+5.3%	$34.82M-31.7%	$30.82M-33.3%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	400M0.0%	400M+5,714,186%	400M0.0%	400M0.0%	400M0.0%
Additional paid-in capital	$429.12M+5.4%	$424.62M+4.3%	$419.71M+3.3%	$411.26M+2.4%	$407.05M+2.4%
Retained earnings	-$143.4M+24.7%	-$145.55M+22.1%	-$136.72M+22.8%	-$194.13M-10.8%	-$190.39M-16.1%
Accumulated other comprehensive income (loss)	$0-100%	$0-100%	$0-100%	$5.97M+115%	$3.07M-1.4%
Total stockholders' equity	$285.73M+30.0%	$279.07M+25.7%	$283M+21.2%	$223.1M-2.7%	$219.73M-7.1%
Total liabilities and stockholders' equity	$327.62M+30.8%	$325.47M+26.8%	$335.08M+18.4%	$257.92M-8.0%	$250.55M-11.4%
Allowance for Doubtful Accounts	$1.01M+949%	$1.07M+852%	——	$315K+13.3%	$96K-24.4%
Allowance for Doubtful Accounts Receivable (Current)	$1.01M+949%	$1.07M+852%	——	$315K+13.3%	$96K-24.4%
Available For Sale Securities Debt Securities Current	$66K-99.9%	$30.26M-72.2%	$53.17M-54.3%	$54.67M-52.7%	$85.18M-25.4%
Other current assets	$6.17M—	$5.01M—	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$24.29M+1,571%	$24.02M+20,253%	$8.58M+839%	$1.46M+57.1%	$1.45M+1.0%
Held-to-Maturity Debt Securities - Fair Value	——	$30.28M-72.2%	$53.16M-54.4%	$54.66M-52.7%	$85.17M-25.4%
Net Investment in Lease	$4.2M-51.5%	$3.11M+9.7%	$3.27M-85.6%	$8.45M-60.0%	$8.65M-64.8%
Other intangible assets—net	$46.31M+242%	$47.5M+496%	$49.75M+256%	$13.58M-0.9%	$13.53M-30.7%
Operating lease right-of-use assets	$4.2M-51.5%	$3.11M+9.7%	$3.27M-85.6%	$8.45M-60.0%	$8.65M-64.8%
Other non-current assets	$24.29M+1,571%	$24.02M+20,253%	$8.58M+839%	$1.46M+57.1%	$1.45M+1.0%
Property, plant and equipment at cost	$47.95M+23.3%	$42.73M+37.7%	$43.5M+24.5%	$40.79M+58.8%	$38.88M—
Operating Lease Right-of-Use Assets in Other Assets	$4.2M-51.5%	$3.11M+9.7%	$3.27M-85.6%	$8.45M-60.0%	$8.65M-64.8%
Software and Technology Licenses, Net	$24.29M+1,571%	$24.02M+20,253%	$8.58M+839%	$1.46M+57.1%	$1.45M+1.0%
Accounts payable and other current liabilities (Note 11)	$19.96M+90.0%	$19.14M+108%	$27.22M+69.8%	$13.68M-18.9%	$10.51M-3.1%
Contingent Consideration Liability (Non-Current)	$1.84M—	$4.63M—	——	——	——
Total debt	$4.47M-50.7%	$3.31M-64.5%	$3.47M-85.4%	$8.84M-59.8%	$9.07M-64.5%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	86.5M+6.9%	86.7M+9.2%	86.1M+9.9%	81.7M+4.8%	81M+5.0%
Common Stock Shares Outstanding	$10.42M—	——	$12M—	$13.47M—	——
Convertible Preferred Stock Authorized Shares	2M0.0%	2M0.0%	2M0.0%	2M0.0%	2M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—	0—
Cumulative Gross Losses and Impairments	——	——	$1K-99.5%	$7K-92.9%	$5K-93.6%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$7K0.0%	$7K0.0%	$7K0.0%	$7K0.0%	$7K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Number of Exercisable Options	2.6M—	——	3.1M—	3.5M—	——
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment - Nonvested Awards (Number)	13.6M—	9.7M—	——	——	——
Share-Based Payment Award Options Outstanding - Number	2.6M—	2.9M-43.5%	3.1M—	3.5M—	——
Share-Based Payment - Unrecognized Cost of Nonvested Awards	$3.95—	$3.84—	——	——	——
Weighted Average Exercise Price of Outstanding Options	$0.19—	$0.190.0%	$0.19—	$0.19—	——
Cumulative Cost Basis	$47.95M+23.3%	$42.73M+37.7%	$43.5M+24.5%	$40.79M+58.8%	$38.88M—
Fair Value Measurement Disclosure	$71K-97.7%	$1.53M-73.7%	$2.95M+9.4%	$2.98M+24.5%	$3.06M+106%
Accounts Receivable, Allowance for Credit Loss	$1.01M+949%	$1.07M+852%	——	$315K+13.3%	$96K-24.4%
Business Combination Contingent Consideration Asset Noncurrent	$15.4M—	$15.15M—	——	——	——
Business Combination Contingent Consideration Asset Current	$13.42M—	$12.55M—	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$400M0.0%	$400M0.0%	$400M0.0%	$400M0.0%	$400M0.0%
Common stock, shares issued (in shares)	$86.52M+6.9%	$86.7M+9.2%	$86.05M+9.9%	$81.7M+4.8%	$80.97M+5.0%
Share-based incentive compensation liabilities	$12.98M—	$15.14M—	——	——	——
Deferred income taxes	$271K+54.9%	$348K—	$181K-40.1%	$210K-47.8%	$175K-51.0%
Disposal group, including discontinued operation, equity consideration (in shares)	——	——	5.3M—	——	——
Consideration stock price (in dollars per share)	——	——	$14.15—	——	——
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss	——	——	$1K-99.5%	$7K-92.9%	$5K-93.6%
Indemnity holdback related to sale of business	$8.8M—	$8.7M—	——	——	——
Other	$2.3M—	$2.31M—	——	——	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$2M0.0%	$2M0.0%	$2M0.0%	$2M0.0%	$2M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—	$0—
Prepaid expenses	$5.9M—	$7.18M—	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value	$3.95—	$3.84—	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	$2.61M—	——	$3.13M—	$3.51M—	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$2.61M—	$2.9M-43.5%	$3.13M—	$3.51M—	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.19—	$0.190.0%	$0.19—	$0.19—	——
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number	$13.56M—	$9.75M—	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$10.42M—	——	$12M—	$13.47M—	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$0.19—	——	$0.19—	$0.19—	——
Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value	$0.34—	$0.32+39.1%	$0.31—	$0.29—	——
Exercisable at period end (in dollars per share)	$0.34—	——	$0.31—	$0.29—	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	$10.42M—	——	$12M—	$13.47M—	——
Unfulfilled performance obligations	$2.3M—	——	$3.19M—	——	——
Warrants And Rights Outstanding	$71K-97.7%	$1.53M-73.7%	$2.95M+9.4%	$2.98M+24.5%	$3.06M+106%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Strata Critical Medical, Inc. Class A Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Strata Critical Medical, Inc. Class A Common Stock's total assets?: Strata Critical Medical, Inc. Class A Common Stock (SRTA) holds $327.6M in total assets, up 30.8% year over year.
How much debt does Strata Critical Medical, Inc. Class A Common Stock have?: Strata Critical Medical, Inc. Class A Common Stock carries $4.5M in total debt against $285.7M of shareholders' equity, a debt-to-equity ratio of 0.02.
How much cash does Strata Critical Medical, Inc. Class A Common Stock have?: Strata Critical Medical, Inc. Class A Common Stock holds $59.0M in cash and equivalents.
Can Strata Critical Medical, Inc. Class A Common Stock cover its short-term obligations?: Its current ratio is 5.93 — current assets exceed current liabilities.
Where does Strata Critical Medical, Inc. Class A Common Stock's balance sheet data come from?: Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.